Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: progressive doe and fatigue major surgical or invasive procedure: cabgx4 (lima->lad, svg->pda, svg->om, svg->d1) history of present illness: mr is a 64 year old man who reported activity intolerance over the past year. a cardiac catheterization prior to admission showed 3vd and normal hemodynamics.he was therefore admitted on for an elective cabg. past medical history: dm2 dyslipidemia pvd with le claudication gerd depression diabetic neuropathy cri(1.9) social history: divorced, estranged from immediate family former etoh -tob on disability family history: non contributory physical exam: nad 140/70, 84 sr heent - chest ctab cv: rrr -m/r/g, no edema, +pp neuro: mae pertinent results: 05:50am blood hct-29.2* 05:50am blood urean-58* creat-2.0* k-4.8 06:00am blood urean-61* creat-2.0* 05:20am blood glucose-80 urean-62* creat-2.2* na-138 k-4.1 cl-101 hco3-24 angap-17 brief hospital course: ms. was trasferred to the sicu in critical but stable condition on phenylephrine at 0.1. he was extubated by pod # 1. his drips were weaned by pod#3, however he was started on natrecor for several days. he was transferred to the staerp down unit by post op day 5.his creatinine rose from baseline to 2.2 however returned to baseline within 2 days. he failed a voiding trial and was started on flomax... medications on admission: avandia 8 qd, glipizide er 10 qd, zoloft 150 , 81 qd, avapro 150 qd, crestor 10 qd, insulin 70/30 20 units qhs discharge medications: 1. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). tablet(s) 2. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). 3. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 4. fluticasone 110 mcg/actuation aerosol sig: two (2) puff inhalation (2 times a day). 5. glipizide 5 mg tab, sust release osmotic push sig: two (2) tab, sust release osmotic push po daily (daily). 6. ipratropium bromide 0.02 % solution sig: one (1) inhalation q6h (every 6 hours) as needed. 7. tamsulosin 0.4 mg capsule, sust. release 24hr sig: one (1) capsule, sust. release 24hr po hs (at bedtime). 8. pantoprazole sodium 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 9. rosuvastatin calcium 10 mg tablet sig: one (1) tablet po daily (daily). 10. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. 11. rosiglitazone maleate 2 mg tablet sig: four (4) tablet po daily (daily). 12. albuterol 90 mcg/actuation aerosol sig: two (2) puff inhalation q6h (every 6 hours). 13. sertraline 50 mg tablet sig: three (3) tablet po daily (daily). 14. potassium chloride 20 meq packet sig: one (1) packet po q12h (every 12 hours). 15. furosemide 20 mg tablet sig: one (1) tablet po bid (2 times a day). discharge disposition: extended care facility: - discharge diagnosis: cad dm2 pvd gerd depression neuropathy cri(1.9) discharge condition: good. discharge instructions: shower daily, washi incision with mild soap and water and pat dry. no lotions, creams or powders, no baths. no lifting more than 10 pounds or driving until after follow up appointment with surgeon. call with temperature more than 101.5, redness or drainage from incision, or weight gain more than 2 pounds in one day or five in one week. followup instructions: dr. 4 weeks dr. 2 weeks dr. 2 weeks procedure: (aorto)coronary bypass of three coronary arteries single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery transfusion of packed cells injection or infusion of nesiritide diagnoses: coronary atherosclerosis of native coronary artery esophageal reflux intermediate coronary syndrome mitral valve disorders atherosclerosis of native arteries of the extremities with intermittent claudication diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes other and unspecified hyperlipidemia unspecified disorder of kidney and ureter retention of urine, unspecified 

Answer: The patient is high likely exposed to